Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    "Allergic bronchopulmonary aspergillosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis;   A. Fumigatus
Intervention: Dietary Supplement: cholecalciferol (Vitamin D3)
2 Completed Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Glucocorticoids
3 Recruiting Protocol TARC-ABPA
Condition: Allergic Broncho-Pulmonary Aspergillosis
Intervention: Other: Study of predictive factors
4 Unknown  Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
Intervention:
5 Terminated
Has Results
An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Omalizumab;   Drug: Placebo;   Drug: Itraconazole
6 Recruiting Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Prednisolone;   Drug: Voriconazole
7 Unknown  Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Glucocorticoids
8 Recruiting A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Inhaled budesonide;   Drug: Inhaled amphotericin
9 Not yet recruiting Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Liposomal amphotericin B (Ambisome®)
10 Completed Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)
Condition: Cystic Fibrosis,
Intervention:
11 Completed Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients
Conditions: Cystic Fibrosis;   Chit1
Intervention:

Indicates status has not been verified in more than two years